Brookfield Asset Management Inc
BROOKFIELD NEWS, March 24, 2021 (GLOBE NEWSWIRE) -- Brookfield Asset Management Inc. (NYSE: BAM) (TSX: BAM.A) announced today that it has filed its 2020 annual materials on Form 40-F, including its audited financial statements and management’s discussion and analysis for the year ended December 31, 2020, with the SEC on EDGAR as well as with the Canadian securities authorities on SEDAR. These documents are also available at www.brookfield.com and a hard copy will be provided to shareholders free of charge upon request.
Brookfield Asset Management Inc. is a leading global alternative asset manager with US$600 billion of assets under management across real estate, infrastructure, renewable power, private equity and credit. Brookfield owns and operates long-life assets and businesses, many of which form the backbone of the global economy. Utilizing its global reach, access to large-scale capital and operational expertise, Brookfield offers a range of alternative investment products to investors around the world—including public and private pension plans, endowments and foundations, sovereign wealth funds, financial institutions, insurance companies and private wealth investors. Brookfield Asset Management is listed on the New York and Toronto stock exchanges under the symbol BAM and BAM.A respectively.
For more information, please visit our website at www.brookfield.com or contact:
Communications & Media: Claire Holland Tel: (416) 369-8236 Email: claire.holland@brookfield.com | Investor Relations: Linda Northwood Tel: (416) 359-8647 Email: linda.northwood@brookfield.com |
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sanofi Winthrop Industrie17.10.2025 13:05:00 CEST | Press release
Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
Sanofi Winthrop Industrie17.10.2025 13:00:00 CEST | Press release
Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease
CrossAmerica Partners17.10.2025 12:45:00 CEST | Press release
CrossAmerica Partners to Announce Third Quarter 2025 Earnings Results on November 5
Novartis Pharma AG17.10.2025 12:37:04 CEST | Press release
Novartis Scemblix® receives positive CHMP opinion for the treatment of adults with newly diagnosed CML
iFLYTEK17.10.2025 12:33:00 CEST | Press release
iFLYTEK AINOTE 2 Launches: A Game-Changer for Professional Productivity
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom